Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
2 "Disease activity index"
Filter
Filter
Article category
Publication year
Original Article
Inflammatory Bowel Diseases
Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja
Intest Res 2021;19(3):291-300.   Published online May 26, 2020
DOI: https://doi.org/10.5217/ir.2019.09172
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients at a tertiary care hospital in India.
Methods
This was a retrospective analysis of CD patients who received EEN as a sole modality/adjunct to other treatment. The primary and secondary outcomes changed in Crohn’s Disease Activity Index (CDAI), and clinical response (decline in CDAI > 70), respectively, at 4 and 8 weeks. Subgroup analysis evaluated response across different phenotypes, EEN formulations and prior treatment. Linear mixed effect model was created to assess the predictors of EEN response.
Results
Thirty-one CD patients received EEN over median duration of 4 weeks (range, 2–6 weeks). CDAI showed a significant improvement post EEN at 4 (baseline 290 [260–320] vs. 240 [180–280], P= 0.001) and 8 weeks (baseline 290 [260–320] vs. 186 [160–240], P= 0.001), respectively. The cumulative clinical response rates at 4 and 8 weeks were 37.3% and 80.4% respectively. The clinical response rates at 8 weeks across B1 (n = 4), B2 (n = 18) and B3 (n = 9) phenotypes were 50%, 78.8% and 100% respectively (log-rank test, P= 0.093). The response rates at 8 weeks with polymeric (n = 8) and semi-elemental diet (n = 23) were 75% and 82.6%% respectively (log-rank test, P= 0.49). Baseline CDAI (odds ratio, 1.008; 95% confidence interval, 1.002–1.017; P= 0.046) predicted response to EEN.
Conclusions
EEN was effective in inducing clinical response across different phenotypes of CD. Baseline disease activity remained the most important predictor of clinical response to EEN.

Citations

Citations to this article as recorded by  
  • Advancing Clinical Trial Methodology and Reporting of Outcomes for Exclusive Enteral Nutrition and Partial Enteral Nutrition in Crohn's Disease: Challenges and Recommendations
    Sarah L. Melton, Jessica Fitzpatrick, Matthew K. W. Chu, Konstantinos Gkikas, Emily Monro, Jemma Matthews, Emma P. Halmos, Alice S. Day
    JCC Plus.2026;[Epub]     CrossRef
  • Using machine learning to predict clinical remission with exclusive enteral nutrition in pediatric Crohn disease
    Ricardo G. Suarez Suarez, Daniel G. McClement, Roberto Vega, Hien Q. Huynh, Ayub Shaikh, Anthony Otley, Kevan Jacobson, Mary Sherlock, David R. Mack, Colette Deslandres, Wael El‐Matary, Eileen Crowley, Jennifer deBruyn, Thomas Walters, Anne M. Griffiths,
    Journal of Pediatric Gastroenterology and Nutrition.2026; 82(2): 465.     CrossRef
  • ECCO consensus on management of inflammatory bowel disease in low- and middle-income countries
    Alaa El-Hussuna, Almuthe Christina Hauer, Tarkan Karakan, Valerie Pittet, Henit Yanai, Jalpa Devi, Jesus K Yamamoto-Furusho, Ali Reza Sima, Hailemichael Desalegn, Mutaz Idrees Sultan, Vishal Sharma, Hany Shehab, Lamya Mrabti, Natalia Queiroz, Anuraag Jena
    Journal of Crohn’s and Colitis.2026;[Epub]     CrossRef
  • The Crohn's Disease Exclusion Diet Across the Lifespan, Indications and the Globe: An Expert Review Towards Personalized Therapy in Crohn's Disease
    Rotem Sigall Boneh, Elena Banci, Luca Scarallo, Marta Herrador‐López, Emma P. Halmos, Dror S. Shouval, Nicolette Wierdsma, Chen Sarbagili‐Shabat, Víctor Manuel Navas‐López, Javier Martín‐de‐Carpi, Yulia Ron, Lindsey Albenberg, Henit Yanai, Franck Carbonne
    JCC Plus.2026;[Epub]     CrossRef
  • Exclusive enteral nutrition for induction of remission in Crohn’s disease in adults: A systematic review and meta-analysis of randomized trials and real-world studies
    Kirandeep Kaur, Arshdeep Singh, Simrat Kaur, Riya Sharma, Sanya Malik, Arshia Bhardwaj, Anuraag Jena, Ramit Mahajan, Vandana Midha, Ajit Sood
    Indian Journal of Gastroenterology.2026; 45(3): 452.     CrossRef
  • Exclusive enteral nutrition and infliximab combination therapy are superior to monotherapy in inducing endoscopic response in active adult Crohn’s disease
    Xinglan Li, Xudong Wu, Dengfeng Kang, Leilei Fang, Changqin Liu, Yanhong Shi, Li Yang, Zhanju Liu, Liang Chen
    Therapeutic Advances in Gastroenterology.2026;[Epub]     CrossRef
  • Exclusive enteral nutrition improves radiological outcomes in adults with perianal fistulizing Crohn's disease: A real‐world retrospective cohort study
    Xiaoxia Deng, Zicheng Huang, Qiuyue Xia, Zhaopeng Huang, Yue Wu, Yanhui Wu, Qing Li, Na Diao, Miao Li, Jian Tang, Qin Guo, Xiang Gao, Qing fan Yang, Kang Chao
    Nutrition in Clinical Practice.2026; 41(4): 1144.     CrossRef
  • Alternative Medicine and Nutritional Therapy in Adult Inflammatory Bowel Disease in India: A Move Towards Holistic Practice
    Prerana Ghosh, Karan Varshney
    Cureus.2026;[Epub]     CrossRef
  • Adjunct polymeric exclusive enteral nutrition helps achieve biochemical remission in active Crohn’s disease in adults irrespective of disease location and concomitant corticosteroid use
    Hellen Kuo, Katrina Tognolini, Rumbidzai Mutsekwa, Dheeraj Shukla, Laura Willmann, Hadi Moattar, Alexander Dorrington, Naveed Ishaq, Maneesha Bhullar, John Edwards, Waled Mohsen, Pradeep Kakkadasam Ramaswamy
    Frontline Gastroenterology.2025; 16(1): 3.     CrossRef
  • Inflammatory bowel disease in south Asia: a scoping review
    Shabari Shenoy, Anuraag Jena, Carrie Levinson, Vishal Sharma, Parakkal Deepak, Tina Aswani-Omprakash, Shaji Sebastian, Jean-Frederic Colombel, Manasi Agrawal
    The Lancet Gastroenterology & Hepatology.2025; 10(3): 259.     CrossRef
  • Enteral Nutrition in Crohn’s Disease: A Comprehensive Review of Its Role in Induction and Maintenance of Remission and Perioperative Management in Adult Patients
    André Bargas, Carolina Palmela, Luisa Glória
    Nutrients.2025; 17(9): 1481.     CrossRef
  • Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial
    Jian Kang, Jing Wang, Juan Su, Wei Wang, Yueyue Lu, Zhishun Tang, Liping Zou, Anning Yin, Jiao Li, Haixia Ren, Qian Zhou, Huipeng Wan, Ping An
    United European Gastroenterology Journal.2025; 13(6): 997.     CrossRef
  • The Role of Diet in Crohn’s Disease: From Etiology to Evidence-Based Management
    Fares Jamal, Mayar H Alatout, Muhammad Ali Khan, Syed B Pasha, Talha A Malik
    Cureus.2025;[Epub]     CrossRef
  • Frequent Dietetic Involvement Enhances Adherence and Clinical Outcomes of Exclusive Enteral Nutrition in Adults With Crohn's Disease
    Matthew K. W. Chu, Alice S. Day, Damjana Bogatic, Martine Hatzi, Samuel K. S. Chu, Samuel P. Costello, Robert V. Bryant
    JGH Open.2025;[Epub]     CrossRef
  • Nourishing remission: the role of Crohn’s disease exclusion diet and partial enteral nutrition in pregnancy: a comprehensive review
    Sara Micallef, Franziska Mintoff, Pierre Ellul, Martina Sciberras
    European Journal of Gastroenterology & Hepatology.2025; 37(10): 1180.     CrossRef
  • Crohn's disease and nutrition: current perspectives on dietary therapy and nutritional support
    O. B. Shchukina, V. A. Samoletova, A. V. Isakova
    Medical alphabet.2025; (13): 16.     CrossRef
  • The Role of Nutritional Therapy in the Treatment of Adults with Crohn’s Disease: A Review
    Raffaele Li Voti, Fabio Salvatore Macaluso, Elena Banci, Angelo Campanozzi, Giulia D’Arcangelo, Alessia De Blasi, Salvatore Oliva, Elena Sofia Pieri, Sara Renzo, Cosimo Ruggiero, Giusy Russo, Luca Scarallo, Paolo Lionetti, Ambrogio Orlando
    Nutrients.2025; 17(20): 3186.     CrossRef
  • Progress and Clinical Applications of Crohn’s Disease Exclusion Diet in Crohn’s Disease
    Duo Xu, Ziheng Peng, Yong Li, Qian Hou, Yu Peng, Xiaowei Liu
    Gut and Liver.2024; 18(3): 404.     CrossRef
  • Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline
    Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignass, Robert Ehehalt, Christoph-Thomas Germer, P. C. Grunert, Ulf Helwig, Karoline Horisberger, Klaus Herrlinger, Peter Kienle, Torsten Kucharzik, Jost Langhorst, Christian Maaser,
    Zeitschrift für Gastroenterologie.2024; 62(08): 1229.     CrossRef
  • Refractory Crohn’s Disease: Perspectives, Unmet Needs and Innovations
    Luisa Bertin, Martina Crepaldi, Miriana Zanconato, Greta Lorenzon, Daria Maniero, Caterina De Barba, Erica Bonazzi, Sonia Facchin, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Andrea Buda, Fabiana Zingone, Edoardo Vincenzo Savarino, Brigida Barberio
    Clinical and Experimental Gastroenterology.2024; Volume 17: 261.     CrossRef
  • Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease
    Kush Fansiwala, Neha D. Shah, Kelly A. McNulty, Mary R. Kwaan, Berkeley N. Limketkai
    Nutrition in Clinical Practice.2023; 38(6): 1282.     CrossRef
  • Exclusive Enteral Nutrition Orchestrates Immunological Balances as Early as Week 4 in Adult Patients of Crohn’s Disease: A Pilot, Open-Lable Study
    Na Diao, Xinyu Liu, Minzhi Lin, Qingfan Yang, Bingyang Li, Jian Tang, Ni Ding, Xiang Gao, Kang Chao
    Nutrients.2023; 15(24): 5091.     CrossRef
  • Exclusive enteral nutrition with oral polymeric diet helps in inducing clinical and biochemical remission in adults with active Crohn's disease
    Pradeep Kakkadasam Ramaswamy
    Journal of Parenteral and Enteral Nutrition.2022; 46(2): 423.     CrossRef
  • Is the frequency of dietitian support associated with greater clinical improvements in adults with Crohn's disease undertaking exclusive enteral nutrition?
    Liz Purcell, Rumbidzai Mutsekwa, Rebecca Angus, Dheeraj Shukla, Michelle Palmer
    Journal of Human Nutrition and Dietetics.2022; 35(3): 435.     CrossRef
  • Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004
    Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Oc
    Zeitschrift für Gastroenterologie.2022; 60(03): 332.     CrossRef
  • Diet and nutrition in the management of inflammatory bowel disease
    Pabitra Sahu, Saurabh Kedia, Vineet Ahuja, Rakesh K. Tandon
    Indian Journal of Gastroenterology.2021; 40(3): 253.     CrossRef
  • Review of exclusive enteral therapy in adult Crohn’s disease
    Nikola Mitrev, Hin Huang, Barbara Hannah, Viraj Chandana Kariyawasam
    BMJ Open Gastroenterology.2021; 8(1): e000745.     CrossRef
  • Current Use of EEN in Pre-Operative Optimisation in Crohn’s Disease
    Sharafaath Shariff, Gordon Moran, Caris Grimes, Rachel Margaret Cooney
    Nutrients.2021; 13(12): 4389.     CrossRef
  • Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers
    Roberto de Sire, Olga Maria Nardone, Anna Testa, Giulio Calabrese, Anna Caiazzo, Fabiana Castiglione
    Clinical and Experimental Gastroenterology.2021; Volume 14: 493.     CrossRef
  • Making Decisions about Dietary Therapy in Inflammatory Bowel Disease
    Sydney Solomon, Eunie Park, Joseph A. Picoraro
    Gastrointestinal Disorders.2020; 2(4): 353.     CrossRef
  • EEN Yesterday and Today … CDED Today and Tomorrow
    Marta Herrador-López, Rafael Martín-Masot, Víctor Manuel Navas-López
    Nutrients.2020; 12(12): 3793.     CrossRef
  • 16,277 View
  • 335 Download
  • 26 Web of Science
  • 31 Crossref
Close layer
Focused Review: Intestinal Behçet's Disease
Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease
Hyun Jung Lee, Jae Hee Cheon
Intest Res 2017;15(3):311-317.   Published online June 12, 2017
DOI: https://doi.org/10.5217/ir.2017.15.3.311
AbstractAbstract PDFPubReaderePub

Intestinal Behçet's disease (BD), generally accepted as a type of inflammatory bowel disease (IBD), could be diagnosed when patients with BD have objectively documented gastrointestinal symptoms and intestinal ulcerations. Similar to IBD, intestinal BD has an unpredictable disease course with relapse and remission and is often related to a poor prognosis. However, there is no single gold standard for assessment of the disease activity of intestinal BD, and its diagnosis and management depend heavily on expert opinions. The Korean IBD Study Group recently developed novel diagnostic criteria based on colonoscopy findings and clinical manifestations using a modified Delphi process to overcome drawbacks of previously used consensus for the diagnosis of intestinal BD. In addition, the recently developed disease activity index for intestinal BD, consisting of a relatively simple 8-point index, could also help in determining treatment strategies and monitoring therapeutic responses. In this review, the progress in the diagnosis and disease activity measurement of intestinal BD will be discussed.

Citations

Citations to this article as recorded by  
  • A case of intestinal Behçet disease in a deceased donor kidney transplantation recipient
    Miran Park, Jun Su Lee, Soon Man Yoon, Ji Hye Kim, Sun Moon Kim
    Clinical Transplantation and Research.2026; 40(1): 142.     CrossRef
  • Management of Severe Behçet’s Disease
    Kerem Abacar, Haner Direskeneli, Fatma Alibaz-Oner
    Current Rheumatology Reports.2026;[Epub]     CrossRef
  • Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease
    Woojin Ahn, Seoyoon Choi, So Jung Han, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jihye Park, Jae Hee Cheon
    Intestinal Research.2026;[Epub]     CrossRef
  • When Behçet Mimics Crohn's disease: A Diagnostic Challenge
    Judith Heiss, Drilon Haziri, Matthias Kolleck, Kathleen Lange, Nikolaus Gassler, Philipp A. Reuken, Andreas Stallmach
    Zeitschrift für Gastroenterologie.2026; 64(07): 914.     CrossRef
  • Gastrointestinal Involvement in Pediatric Behçet’s Disease: A Focused Analysis from a Comprehensive Systematic Review
    Dimitri Poddighe, Donato Rigante, Micol Romano, Zaure Mukusheva, Nicola Ughi, Erdal Sag, Selcan Demir, Natalie Zitoun, David Piskin, Erkan Demirkaya
    Diagnostics.2026; 16(19): 3184.     CrossRef
  • Upper Gastrointestinal Involvement in Behcet’s Disease
    Hogyung Jun, Hyun Joo Song, Ji Hwan Mun, Heung Up Kim
    The Korean Journal of Gastroenterology.2025; 85(2): 170.     CrossRef
  • Clinical features and novel pathogenic variants of patients with Behçet’s disease like trisomy 8
    Xingru Ding, Jinghan Yang, Xiao Han, Yi-Fan Shen, Kangkang Yang, Yaoyao Shangguan, Yiwei Dong, Xiaohua Ye
    Orphanet Journal of Rare Diseases.2025;[Epub]     CrossRef
  • Impact of body mass index on clinical outcomes in intestinal Behçet’s disease
    Daye Park, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon
    The Korean Journal of Internal Medicine.2025; 40(4): 606.     CrossRef
  • Predicting Factors of Long-term Outcome of Gastrointestinal Behçet's Disease: A Chinese Retrospective Study
    Xiaoman Zu, Shanshan Xiong, Yaming Lu, Ning Zhang, Shu Xu, Rui Feng, Baili Chen, Zhirong Zeng, Minhu Chen, Yao He
    Clinical Therapeutics.2024; 46(3): 201.     CrossRef
  • Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
    Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
    European Journal of Gastroenterology & Hepatology.2024; 36(4): 445.     CrossRef
  • Safety of Biologics and Small Molecules for Inflammatory Bowel Diseases in Organ Transplant Recipients
    Ga Hee Kim, Minjun Kim, Kyuwon Kim, Jung-Bin Park, Ji Eun Baek, June Hwa Bae, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
    Yonsei Medical Journal.2024; 65(5): 276.     CrossRef
  • Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
    Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
    Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
  • Efficacy and Safety of Anti-Tumor Necrosis Factor-Alpha Agents for Patients with Intestinal Behcet’s Disease: A Systematic Review and Meta-Analysis
    Qingfeng Zhang, Chunyan Ma, Rongrong Dong, Weizhen Xiang, Meiqi Li, Zhenzhen Ma, Qingrui Yang
    Yonsei Medical Journal.2022; 63(2): 148.     CrossRef
  • Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet’s disease: Case report and the review of literature
    Takashi Onaka, Kazuhisa Nakano, Yuri Uemoto, Naoto Miyakawa, Yasuyuki Otsuka, Aiko Ogura-Kato, Fumie Iwai, Yoshiya Tanaka, Akihito Yonezawa
    Modern Rheumatology Case Reports.2022; 6(2): 273.     CrossRef
  • 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging Appearance of Gastrointestinal Behcet’s Disease
    Burak İnce, Ali Kibar, Sertaç Asa, Rabia Lebriz Uslu Beşli, Muhammet Sait Sağer, Ahmet Emre Eşkazan, Ali İbrahim Hatemi, Gülen Hatemi, Kerim Sönmezoğlu
    Molecular Imaging and Radionuclide Therapy.2022; 31(1): 57.     CrossRef
  • Clinical Course of Patients with Intestinal Behçet’s Disease According to Consensus-Based Diagnostic Categories
    Yu Young Joo, Bo-In Lee, Seung-Jun Kim, Han Hee Lee, Jin Su Kim, Jae Myung Park, Young-Seok Cho, Kang Moon Lee, Sang Woo Kim, Hwang Choi, Myung-Gyu Choi
    Gut and Liver.2022; 16(5): 746.     CrossRef
  • Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Differentiate Behçet’s Disease with Intestinal Involvement and Crohn’s Disease
    Fatma Alibaz-Oner, Rabia Ergelen, Ilkay Ergenc, Gizem Seven, Ayten Yazıcı, Ayse Cefle, Cemal Bes, Ozlen Atug, Haner Direskeneli
    Digestive Diseases and Sciences.2021; 66(8): 2750.     CrossRef
  • Deep‐learning system for real‐time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis
    Jung Min Kim, Jun Gu Kang, Sungwon Kim, Jae Hee Cheon
    Journal of Gastroenterology and Hepatology.2021; 36(8): 2141.     CrossRef
  • Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet’s disease from Crohn’s disease
    Jihye Park, Daeun Jeong, Youn Wook Chung, Seunghan Han, Da Hye Kim, Jongwook Yu, Jae Hee Cheon, Ji-Hwan Ryu
    Scientific Reports.2021;[Epub]     CrossRef
  • Behçet syndrome
    Yusuf Yazici, Gulen Hatemi, Bahram Bodaghi, Jae Hee Cheon, Noburu Suzuki, Nicola Ambrose, Hasan Yazici
    Nature Reviews Disease Primers.2021;[Epub]     CrossRef
  • C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
    Eun Ae Kang, Jung Won Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Min Soo Cho, Jae Hee Cheon
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Update on the Treatment of Behcet’s Disease of the Small Bowel with Biologic Agents
    Yehyun Park, Jae Hee Cheon
    Current Gastroenterology Reports.2020;[Epub]     CrossRef
  • A20 Haploinsufficiency in a Chinese Patient With Intestinal Behcet's Disease-Like Symptoms: A Case Report
    Yu Chen, Huanjun Huang, Yao He, Minhu Chen, Ursula Seidler, De'an Tian, Fang Xiao
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20
    Yu Chen, Zhenghao Ye, Liping Chen, Tingting Qin, Ursula Seidler, De'an Tian, Fang Xiao
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Behсet's disease: intestinal damage
    R. G. Goloeva, Z. S. Alekberova
    Rheumatology Science and Practice.2019; 56(6): 767.     CrossRef
  • Successful closure of ileostomy in a patient with intestinal Behçet's disease after therapy with adalimumab
    Zhe Yan, Bei-Bei Cui, Yong-Yang Yu, Geng Yin, Xiao-Min Cen, Qi-Bing Xie
    Medicine.2019; 98(9): e14624.     CrossRef
  • Intestinal manifestations of Behçet's disease
    R G Goloeva, Z S Alekberova, T A Lisitsyna, E A Stepanova, L P Orlova
    Terapevticheskii arkhiv.2019; 91(5): 111.     CrossRef
  • Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
    Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park
    Gut and Liver.2018; 12(4): 433.     CrossRef
  • Updated treatment strategies for intestinal Behçet’s disease
    Yong Eun Park, Jae Hee Cheon
    The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef
  • 18,774 View
  • 221 Download
  • 27 Web of Science
  • 29 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP